Polyendokrine Syndrome beim Hund

Zusammenfassung

Das autoimmune polyendokrine Syndrom (APS) ist eine beim Hund selten vorkommende Kombination autoimmun bedingter endokriner Erkrankungen. Häufige Kombinationen sind Hypothyreose mit Hypoadrenokortizismus oder Diabetes mellitus. Des Weiteren können seltener Hypoparathyreoidismus und Orchitis als Teil eines APS auftreten. Die Diagnose des APS erfolgt über die Diagnose der jeweiligen Erkrankungen. Ebenso besteht die Therapie des APS in der Therapie der beteiligten Erkrankungen, d.h. in der Substitution der defizienten Hormone. Entstehen unter einer zuvor stabilen Therapie einer endokrinen Erkrankung weitere Symptome (z.B. Polyurie, Polydipsie oder Gewichtsverlust), sollte an die zusätzliche Entstehung anderer Endokrinopathien wie Hypoadrenokortizismus oder Diabetes mellitus gedacht werden. Die Diagnose der initial diagnostizierten Endokrinopathie sollte jedoch ebenfalls kritisch hinterfragt werden. Dieser Artikel fasst Fallberichte aus dem eigenen Patientengut sowie ausgewählte Fallberichte aus der Literatur mit ihren Besonderheiten zusammen.

Abstract

The autoimmune polyendocrine syndrome (APS) refers to a combination of autoimmune endocrine disorders. It is rarely described in dogs. The most common combinations are hypoadrenocorticism and hypothyroidism, followed by diabetes mellitus, and less often hypoparathyroidism and orchitis. The diagnosis of the APS is based on the diagnosis of each endocrinopathy, as is the therapy, which involves the substitution of deficient hormones. If a patient was previously stable under treatment and is showing further signs (e.g. polyuria, polydipsia, or weight loss), the development of additional endocrinopathies like hypoadrenocorticism or diabetes mellitus should be considered. The diagnosis of the initially diagnosed endocrinopathy should also be critically questioned. This article summarizes some cases of our own animal hospital and selected cases published in the available literature.

Schlüsselwörter

Endokrinologie - Autoimmunität - Schmidt-Syndrom - Hypoadrenokortizismus - Hypothyreose - Diabetes mellitus

Key words

Endocrinology - autoimmunity - Schmidt’s syndrome - hypoadrenocorticism - hypothyroidism - diabetes mellitus

Publikationsverlauf

Eingereicht: 31. Oktober 2022

Angenommen: 18. Juni 2023

Artikel online veröffentlicht:
13. November 2023

• Literatur

• 1 Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004; 350: 2068-2079
• 2 Husebye ES, Anderson MS, Kämpe O. Autoimmune polyendocrine syndromes. N Engl J Med 2018; 378: 1132-1141
• 3 Scott-Moncrieff JCR. Hypoadrenocorticism. In: Canine and Feline Endocrinology. 4th edn. Feldman EC, Nelson RW, Reusch CE, Scott-Moncrieff JCR. Saunders Elsevier; 2015: 485-520
• 4 Blois SL, Dickie E, Kruth SA. et al. Multiple endocrine diseases in dogs: 35 cases (1996-2009). J Am Vet Med Assoc 2011; 238: 1616-1621
• 5 Vanmal B, Martlé V, Binst D. et al. Combined atypical primary hypoadrenocorticism and primary hypothyroidism in a dog. Vlaams Diergeneeskd Tijdschr 2016; 85: 355-364
• 6 Kuijlaars M, Yool DA, Ridyard AE. Autoimmune polyendocrine syndrome in a standard poodle with concurrent non-endocrine immune-mediated diseases. Vet Rec Case Rep 2021; 9
• 7 Nelson RWCC. Innere Medizin der Kleintiere. 2^nd Aufl. München: Elsevier GmbH, Urban & Fischer Verlag; 2010
• 8 Scott-Moncrieff JCR. Hypoadrenocorticism. In: Textbook of Veterinary Internal Medicine, 7^th edn. Ettinger SJ, Feldman EC. St. Louis, Missouri, USA: Saunders Elsevier; 2010: 1847-1857
• 9 Reagan KL, McLarty E, Marks SL. et al. Characterization of clinicopathologic and abdominal ultrasound findings in dogs with glucocorticoid deficient hypoadrenocorticism. J Vet Intern Med 2022; 36: 1947–1957
• 10 Cartwright JA, Stone J, Rick M. et al. Polyglandular endocrinopathy type II (Schmidt’s syndrome) in a Dobermann pinscher. J Small Anim Pract 2016; 57: 491-494
• 11 McGonigle KM, Randolph JF, Center SA. et al. Mineralocorticoid before glucocorticoid deficiency in a dog with primary hypoadrenocorticism and hypothyroidism. J Am Anim Hosp Assoc 2013; 49: 54-57
• 12 Paik J, Kang J-H, Chang D. et al. Cardiogenic pulmonary edema in a dog following initiation of therapy for concurrent hypoadrenocorticism and hypothyroidism. J Am Anim Hosp Assoc 2016; 52: 378-384
• 13 Furukawa S, Meguri N, Koura K. et al. A case of canine polyglandular deficiency syndrome with diabetes mellitus and hypoadrenocorticism. Vet Sci 2021; 8: 1-6
• 14 Kooistra HS, Rijnberk A, Van Den Ingh TSAGM. Polyglandular deficiency syndrome in a boxer dog: Thyroid hormone and glucocorticoid deficiency. Vet Q 1995; 17: 59-63
• 15 Hwang SY, An JH, Lee JH. et al. Autoimmune polyendocrine syndrome with hypoadrenocorticism and diabetes mellitus in a dog: A rare case. Vet Med Sci 2021; 7: 2120-2123
• 16 Pikula J, Pikulova J, Bandouchova H. et al. Schmidt’s syndrome in a dog: A case report. Vet Med (Praha) 2007; 52: 419-422
• 17 Adissu H, Hamel-Jolette A, Foster R. Lymphocytic adenohypophysitis and adrenalitis in a dog with adrenal and thyroid atrophy. Vet Pathol 2010; 47: 1082-1085
• 18 Reusch CE, Fracassi F, Sieber-Ruckstuhl NS. et al. Altered serum thyrotropin concentrations in dogs with primary hypoadrenocorticism before and during treatment. J Vet Intern Med 2017; 31: 1643-1648
• 19 Ferguson DC. Testing for hypothyroidism in dogs. Vet Clin North Am Small Anim Pract 2007; 37: 647-669
• 20 Brömel C, Pollard RE, Kass PH. et al. Ultrasonographic evaluation of the thyroid gland in healthy, hypothyroid, and euthyroid golden retrievers with nonthyroidal illness. J Vet Intern Med 2005; 19: 499-506
• 21 Shiel RE, Pinilla M, Mcallister H. et al. Assessment of the value of quantitative thyroid scintigraphy for determination of thyroid function in dogs. J Small Anim Pract 2012; 53: 278-285
• 22 Feldman EC. Hypothyroidism. In: Canine and Feline Endocrinology and Reproduction. St. Louis, MO: Elsevier Health Science; 2004: 86-151
• 23 Kantrowitz LB, Peterson ME, Melian C. et al. Serum total thyroxine, total triiodothyronine, free thyroxine, and thyrotropin concentrations in dogs with nonthyroidal disease. J Am Vet Med Assoc 2001; 219: 765-769
• 24 Ford SL, Nelson RW, Feldman EC. et al. Insulin resistance in three dogs with hypothyroidism and diabetes mellitus. J Am Vet Med Assoc 1993; 202: 1478-1480
• 25 Scott-Moncrieff JCR. Clinical signs and concurrent diseases of hypothyroidism in dogs and cats. Vet Clin North Am Small Anim Pract 2007; 37: 709-722
• 26 Kaplan AJ, Peterson ME, Kemppainen RJ. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs. J Am Vet Med Assoc 1995; 207: 445-451
• 27 Baumstark ME, Sieber-Ruckstuhl NS, Müller C. et al. Evaluation of aldosterone concentrations in dogs with hypoadrenocorticism. J Vet Intern Med 2014; 28: 154-159
• 28 DiBartola SP, Autran De Morais H. Disorders of potassium. In: Fluid, electrolyte, and acid-base disorders in Small animal practice. Elsevier; 2012: 92-119
• 29 Platt SR, Chrisman CL, Graham J. et al. Secondary hypoadrenocorticism associated with craniocerebral trauma in a dog. J Am Anim Hosp Assoc 1999; 35: 117-122
• 30 Schlipf M, Fischer A, Patzl M. et al. Laboratory indicators of hypothyroidism and TgAA-positivity in the Eurasian dog breed. PLoS One 2023; 18: e0280906
• 31 Hess RS, Saunders HM, Van Winkle TJ. et al. Concurrent disorders in dogs with diabetes mellitus: 221 cases (1993–1998). J Am Vet Med Assoc 2000; 217: 1166-1173
• 32 Dalin F, Eriksson GN, Dahlqvist P. et al. Clinical and immunological characteristics of autoimmune addison disease: A nationwide swedish multicenter study. J Clin Endocrinol Metab 2017; 102: 379-389
• 33 Erichsen MM, Løvås K, Skinningsrud B. et al. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: Observations from a Norwegian registry. J Clin Endocrinol Metab 2009; 94: 4882-4890
• 34 Hupfeld J, Dölle M, Volk H. et al. Effect of long-term management of hypoadrenocorticism on the quality of life of affected dogs and their owners. Vet Rec 2022;
• 35 Czarnocka B, Ruf J, Ferrand M. et al. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 1985; 190: 147-152
• 36 Winqvist O, Karlsson FA, Kämpe O. 21-hydroxylase, a major autoantigen in idiopathic Addison’s disease. Lancet 1992; 339: 1559-1562
• 37 Graham PA, Refsal KR, Nachreiner RF. Etiopathologic findings of canine hypothyroidism. Vet Clin North Am Small Anim Pract 2007; 37: 617-631
• 38 Ettinger SJ, Edward C. Feldman. Textbook of Veterinary Internal Medicine, 7^th Edition, Volume 2. Book 2013; 1
• 39 Behrend E, Holford A, Lathan P. et al. 2018 AAHA diabetes management guidelines for dogs and cats. J Am Anim Hosp Assoc 2018; 54: 1-21
• 40 González-Villar F, Pérez-Bravo F. Determination of autoantibodies in dogs with diabetes mellitus. Vet world 2021; 14: 2694-2698
• 41 Boag AM, Christie MR, McLaughlin KA. et al. Autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease). PLoS One 2015; 10: 1-16
• 42 Treeful A, Friedenberg S. Identifying autoantibody biomarkers for addison’s disease in dogs. J Immunol 2020; 204: 92.25
• 43 Treeful AE, Coffey EL, Friedenberg SG. A scoping review of autoantibodies as biomarkers for canine autoimmune disease. J Vet Intern Med 2022; 36: 363-378
• 44 Hess RS, Kass PH, Ward CR. Breed distribution of dogs with diabetes mellitus admitted to a tertiary care facility. J Am Vet Med Assoc 2000; 216: 1414-1417
• 45 Greco DS, Feldman EC, Peterson ME. et al. Congenital hypothyroid dwarfism in a family of giant schnauzers. J Vet Intern Med 1991; 5: 57-65
• 46 Nachreiner RF, Refsal KR, Graham PA. et al. Prevalence of serum thyroid hormone autoantibodies in dogs with clinical signs of hypothyroidism. J Am Vet Med Assoc 2002; 220: 466-471
• 47 Rieder J, Seipel J, Biermann K. et al. Kaniner und feliner Diabetes mellitus – ein epidemiologischer Rückblick (1996–2006). Tierarztl Prax Ausg K Kleintiere Heimtiere 2008; 36: 169-175
• 48 Hanson JM, Tengvall K, Bonnett BN. et al. Naturally occurring adrenocortical insufficiency – an epidemiological study based on a swedish-insured dog population of 525,028 dogs. J Vet Intern Med 2016; 30: 76-84
• 49 Guptill L, Glickman L, Glickman N. Is canine diabetes on the increase. In: Recent advances in clinical management of diabetes mellitus, Proc Symp TNAVC. 1999: 24-27
• 50 Mooney CT. Canine hypothyroidism: A review of aetiology and diagnosis. N Z Vet J 2011; 59: 105-114
• 51 Oberbauer AM, Bell JS, Belanger JM. et al. Genetic evaluation of addison’s disease in the portuguese water dog. BMC Vet Res 2006; 2
• 52 Famula TR, Belanger JM, Oberbauer AM. Heritability and complex segregation analysis of hypoadrenocorticism in the standard poodle. J Small Anim Pract 2003; 44: 8-12
• 53 Hughes A, Nelson R, Famula T. et al. Clinical features and heritability of hypoadrenocorticism in Nova Scotia Duck Tolling Retrievers: 25 cases (1994–2006). J Am Vet Med Assoc 2007; 231: 407-412
• 54 Oberbauer A, Benemann K, Belanger J. et al. Inheritance of hypoadrenocorticism in Bearded Collies. Am J Vet Res 2002; 63: 643-647
• 55 Smallwood L, Barsanti J. Hypoadrenocorticism in a family of leonbergers. J Am Anim Hosp Assoc 1995; 31: 301-305
• 56 Peterson ME, Kintzer PP, Kass PH. Pretreatment clinical and laboratory findings in dogs with hypoadrenocorticism: 225 cases (1979-1993). J Am Vet Med Assoc 1996; 208: 85-91
• 57 Short AD, Catchpole B, Boag AM. et al. Putative candidate genes for canine hypoadrenocorticism (Addison’s disease) in multiple dog breeds. Vet Rec 2014; 175: 430
• 58 Short AD, Catchpole B, Kennedy LJ. et al. Analysis of candidate susceptibility genes in canine diabetes. J Hered 2007; 98: 518-525
• 59 Catchpole B, Adams JP, Holder AL. et al. Genetics of canine diabetes mellitus: Are the diabetes susceptibility genes identified in humans involved in breed susceptibility to diabetes mellitus in dogs?. Vet J 2013; 195: 139-147
• 60 Boelaert K, Newby PR, Simmonds MJ. et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 2010; 123: 183.e1-183.e9
• 61 Heeley AM, O’Neill DG, Davison LJ. et al. Diabetes mellitus in dogs attending UK primary-care practices: frequency, risk factors and survival. Canine Med Genet 2020; 7
• 62 Tardo AM, Del Baldo F, Dondi F. et al. Survival estimates and outcome predictors in dogs with newly diagnosed diabetes mellitus treated in a veterinary teaching hospital. Vet Rec 2019; 185: 692-692
• 63 Daminet S. Hypoadrenocorticism in dogs. In: Chronic disease management for small animals. Hoboken, NJ, USA: John Wiley & Sons, Inc; 2017: 159-162
• 64 Van Lanen K, Sande A. Canine hypoadrenocorticism: pathogenesis, diagnosis, and treatment. Top Companion Anim Med 2014; 29: 88-95
• 65 Reusch CE, Boretti F. Hypothyreose beim Hund. Fachpraxis 2006; 49: 2-12